Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROCTO: TSO in Ulcerative Colitis
NCT03565939Phase 2Completed
- Start
- May 2018
- Primary completion
- Jan 2022
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of trichuris suis ova in ulcerative colitis (UC). Started May 2018; status: completed.
02
Drugs
trichuris suis ova
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT03565939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03565939.